Friday - September 11, 2026
Cristales in MedTech Dive: Four Questions About the FDA's Approach to Generative AI
September 10, 2026
DALLAS, Texas, Sept. 10 [Category: BizLaw/Legal] -- Haynes Boone, a law firm, posted the following news:

* * *

Cristales in MedTech Dive: Four Questions About the FDA's Approach to Generative AI

*

September 10, 2026

As the FDA develops guidance for generative AI in medical devices, regulators are weighing how to evaluate the technology's safety and efficacy and monitor its performance over time. Haynes Boone Counsel Kayl . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products